Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Harnessing apoptosis for improved anticancer gene therapy.

David J Waxman1, Pamela S Schwartz

  • 1Division of Cell and Molecular Biology, Department of Biology, Boston University, Boston, Massachusetts 02215, USA. djw@bu.edu

Cancer Research
|December 26, 2003
PubMed
Summary

Novel cancer therapies combine gene therapy with drug treatments to enhance tumor cell death. This strategy uses anti-apoptotic factors to prolong drug effectiveness and improve cancer treatment outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GH-resistant (Laron) mice: gene therapy with a liver-specific GH receptor causes unbalanced upregulation of female-biased and growth-related genes.

Frontiers in endocrinology·2026
Same author

Disease-associated mutations in the STAT5B SH2 domain reprogram hepatic cholesterol and lipid metabolism.

Endocrinology·2026
Same author

HDI-STARR-seq identifies functional GH-regulated sex-biased hepatocyte enhancers linked to liver metabolism and disease.

Endocrinology·2026
Same author

Single Nucleus MultiOmics Links Novel Transcription Factor Motifs to Murine Hepatic Sex Differences in Chromatin Accessibility and Metabolic Dysfunction-Associated Steatotic Liver Disease.

bioRxiv : the preprint server for biology·2025
Same author

Disease-associated mutations in the STAT5B SH2 domain reprogram hepatic cholesterol and lipid metabolism.

bioRxiv : the preprint server for biology·2025
Same author

HDI-STARR-seq Identifies Functional GH-regulated Sex-Biased Hepatocyte Enhancers Linked to Liver Metabolism and Disease.

bioRxiv : the preprint server for biology·2025

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Understanding tumor cell responses to DNA damage is crucial for developing targeted cancer therapies.
  • Proapoptotic factors can sensitize cancer cells to chemotherapy, but antiapoptotic factors are often linked to poor prognosis.
  • Novel strategies explore combining antiapoptotic factors with gene therapy to overcome treatment resistance.

Purpose of the Study:

  • To investigate the potential of combining antiapoptotic factors with gene-directed enzyme prodrug therapy for cancer treatment.
  • To explore how antiapoptotic factors can be used to enhance the efficacy of traditional chemotherapeutic drugs.
  • To adapt this model for other gene therapies targeting cell death pathways.

Main Methods:

  • Utilizing the baculovirus protein p35 (an antiapoptotic, caspase-inhibitory factor) in combination with P-450 gene-directed enzyme prodrug therapy.

Related Experiment Videos

  • Administering cyclophosphamide as a prodrug activated by P-450.
  • Focusing on localized, intratumoral drug metabolite production.

    • Main Results:

    • The combination therapy prolonged localized production of cytotoxic drug metabolites.
    • This approach did not induce tumor cell drug resistance.
    • The antiapoptotic factor acted downstream of mitochondrial transition delays, allowing for ultimate cell death.

    Conclusions:

    • Combining antiapoptotic factors with gene-directed enzyme prodrug therapy offers a promising strategy to enhance cancer treatment.
    • This model can be adapted for other gene therapies, including those targeting death receptor pathways.
    • Amplifying the therapeutic response by maximizing cytotoxic factors and prodrug metabolites is achievable.